BridgeBio Pharma, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
BBIO on Nasdaq
Location
3160 Porter Dr., Suite 250, Palo Alto, CA

Insiders trading volume in the past year

BridgeBio Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viking Global Investors Lp 10%+ Owner $770M -$107M -12.2% Jan 31, 2025
KKR Genetic Disorder L.P. 10%+ Owner $635M -$347M -35.3% Mar 5, 2025
Neil Kumar Chief Executive Officer, Director $233M -$29.5M -11.2% Mar 25, 2025
Charles J. Homcy Director $45.8M Jun 21, 2024
Frank Mccormick Director $28.6M Dec 26, 2024
Thomas Trimarchi President and CFO $17.1M Mar 19, 2025
Brian C. Stephenson CFO and Treasurer $6.44M -$3.1M -32.5% Feb 25, 2025
Maricel Apuli Chief Accounting Officer $4.84M Mar 19, 2025
Ali J. Satvat Director $4.18M Dec 30, 2024
Richard H. Scheller Director $2.42M Feb 16, 2023
Brent L. Saunders Director $668K Jun 22, 2022
Andrea Ellis Director $420K -$1.37M -76.6% Apr 14, 2025
Randal W. Scott Director $282K -$75.8K -21.2% Jun 21, 2024
Hannah Valantine Director $169K -$420K -71.2% Mar 6, 2025
Ronald J. Daniels Director Jun 21, 2024
Jennifer Cook Director Jun 21, 2024
Fred Hassan Director Jun 21, 2024
James C. Momtazee Director Jun 21, 2024
Eric Aguiar Director Jun 21, 2024
Douglas A. Dachille Director Jun 21, 2024
Andrew Lo Director Jun 21, 2024

Recent Insider Transactions by Companies or Individuals for BridgeBio Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.